Tracking the COVID-19 vaccines: The global landscape-Reference-Cited by-同舟云学术

Tracking the COVID-19 vaccines: The global landscape

Published:2023-01-02 Issue:1 Volume:19 Page:
ISSN:2164-5515
Container-title:Human Vaccines & Immunotherapeutics
language:en
Short-container-title:Human Vaccines & Immunotherapeutics

Author:

Yadav Tushar¹,Kumar Swatantra²³⁴,Mishra Gourav⁵,Saxena Shailendra K.²³⁴^ORCID

Affiliation:

1. Department of Zoology, Jawaharlal Nehru Smriti Government Post Graduate College, Shujalpur, India

2. Centre for Advanced Research (CFAR), Faculty of Medicine, King George’s Medical University (KGMU), Lucknow, India

3. World Society for Virology, Northampton, MA, USA

4. The Indian Virological Society, New Delhi, India

5. Department of Biotechnology, Meerut Institute of Engineering and Technology, Meerut, India

Funder

received

Publisher

Informa UK Limited

Subject

Pharmacology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/21645515.2023.2191577

Reference49 articles.

1. WHO. World Health Organization. COVID-19 vaccine tracker and landscape. 2022. [accessed 2022 Dec 30]. https://www.who.int/publications/m/item/draft-landscape-of-covid-19-candidate-vaccines.

2. Basta NE Moodie EMM on behalf of the VIPER (Vaccines infectious disease prevention and epidemiology research) Group COVID-19 vaccine development and approvals tracker team. COVID-19 vaccine development and approvals tracker. 2020. [accessed 2022 Dec 30]. https://covid19.trackvaccines.org/.

3. Structural Genomics of SARS-CoV-2 Indicates Evolutionary Conserved Functional Regions of Viral Proteins

4. Transmission dynamics and mutational prevalence of the novel Severe acute respiratory syndrome coronavirus‐2 Omicron Variant of Concern

5. Viral targets for vaccines against COVID-19

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The breakthrough in vaccination: Nobel Prize in Physiology or Medicine 2023;Structural Chemistry;2024-02-05

2. Clinical and laboratory considerations: determining an antibody-based composite correlate of risk for reinfection with SARS-CoV-2 or severe COVID-19;Frontiers in Public Health;2023-12-28

3. Head-to-Head Comparison of Novel Vaccine Technologies Comes with a Minefield of Challenges;Pharmaceutics;2023-12-20

4. Protection of the receptor binding domain (RBD) dimer against SARS-CoV-2 and its variants;Journal of Virology;2023-11-30

5. COVID‐19 and cancer: Dichotomy of the menacing dilemma;MedComm – Oncology;2023-11-30